Mesoblast

-$0.06 (-1.02%) As of 2:05 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.

CEO
Silviu Itescu
Employees
83
Headquarters
Melbourne, Victoria (VIC)
Founded
2004

MESO Key Statistics

Market cap
797.43M
Price-Earnings ratio
—
Dividend yield
—
Average volume
200.84K
High today
$5.91
Low today
$5.41
Open price
$5.62
Volume
414.56K
52 Week high
$17.37
52 Week low
$5.13

MESO Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.03 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure